Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 26, 2013

Court of Appeals Ruling on Teva Copaxone® Patent Allows Mylan May 2014 Launch

Jul 26, 2013

Mylan Confirms First-to-File Patent Challenge Relating to BANZEL®

Jul 25, 2013

Mylan Announces STALEVO® Settlement Agreement

Jul 24, 2013

Mylan Announces TARCEVA® Settlement Agreement

Jul 23, 2013

Third Circuit Rules in Mylan's Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylan's Breach of Contract Claim Against GSK to Trial

Jul 18, 2013

Mylan to Host Investor Day on Aug. 1, 2013 in New York City

Jul 18, 2013

Teva Found on Summary Judgment to Infringe Mylan Patent for Perforomist® Inhalation Solution

Jul 16, 2013

Court Finds in Favor of Mylan in Patent Infringement Suit Related to Certain Teva Copaxone® Patents

Jul 16, 2013

Mylan Launches Generic Nor-Q.D.® Tablets, 0.35 mg (28-Day Cycle)

Jul 15, 2013

Mylan Launches One of the First Generic Versions of Trilipix® Capsules

Pagination

First page
Previous page
…
Page 50
Page 51
Page 52
Page 53
Current page 54
Page 55
Page 56
Page 57
Page 58
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.